Oddo BHF - Adevinta ASA (ADE) Adevinta : Takeover bid at NOK 115/share from the Permira-Blackstone consortium. Neutral vs Outperform

Report

Oddo BHF

Jerôme Bodin ...

Martin Marandon-Carlhian

Adevinta : Takeover bid at NOK 115/share from the Permira-Blackstone consortium. Neutral vs Outperform

>Takeover bid at NOK 115/share from the Permira-Blackstone consortium - Yesterday evening, a consortium of private equity funds led by Permira-Blackstone (Permira, Blackstone, General Atlantic and TCV) announced a bid for all Adevinta’s outstanding shares at a price of NOK 115 per share, 8% above the closing price of 21 November. The bid values the group at € 12.1bn (19x 2023e EBITDA) and represents a premium of 54% on the average share price over the three months pri...

22/11/2023 1 EN

Underlying

Adevinta ASA

See profile

NO0010844038 Oslo Bors Norway

Provider

Oddo BHF

Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

See profile

Analysts

Jerôme Bodin

Martin Marandon-Carlhian

Other Reports on these Companies

Oddo BHF

Credit Morning 04/25/2024

Atos: weak Q1 2024 results, need for fresh funds has already increasedVerisure launches a new term loan; new bonds to followVerallia: Q1 2024 logically weak but the recovery in demand is confirmedAngloAmerican Plc: Takeover offer from BHP Group for the entire share capital>...

April 25, 2024 April 25, 2024 1 EN

Oddo BHF

Morning Crédit 25/04/2024

Atos : faibles résultats au T1 2024, les besoins de nouveaux fonds a augmentéVerisure lance un nouveau term loan ; des nouvelles obligations suivrontVerallia : T1 2024 logiquement faible mais la reprise de la demande se confirmeAngloAmerican PLC : Offre de rachat sur la totalité du capital par BHP>...

April 25, 2024 April 25, 2024 1 FR

Oddo BHF

Credit Morning 02/29/2024

ams OSRAM: cancellation of a key microLED project Forvia issues € 800m of new bonds to refinance part of its 2025 and 2026 maturities via a tender offer Nexity: after 2023 broadly in line with expectations, 2024 will remain a year of transition Clariane: FY23 results in line with management expectations, but the financial situation still needs to be improved. The group announces the sale of its UK operations for €243m.>...

February 29, 2024 February 29, 2024 1 EN

Ørsted : Good performance in offshore encouraging

>Results a shade below forecasts but a positive performance in offshore - EBITDA Q1 2024 was DKK 7,488m (+8%) vs DKK 7,700m estimated (ODDO BHF and consensus) and EBIT was DKK 5,065m (+13%) vs DKK 5,200m (ODDO BHF) and DKK 5,400m (consensus). Adjusted net income was below forecasts at DKK 2,609m (-19%) vs ODDO BHF and the consensus at DKK c.3,400m. The reason for the difference in net income was due to the recognition of a deferred tax liability related to an initial...

8h / 12m 8h / 12m 1 FR

Klaus Breitenbach

Klaus Breitenbach

Leifheit AG : Making life at home easier and more convenient

Founded in 1959, Leifheit AG is one of the leading European brand suppliers of household items. The group divides its operating business into the household, wellbeing and private label segments. In view of its growing turnover (CAGR of +2.8% for 2023 to 2026e) and EBIT margins (+290bp to 5.2% in 2026e vs 2023), as well as its solid financial profile (equity ratio of about 50%, average net cash position of c. € 40m for 2024e to 2026e, average positive FCF of c. € 11m for 2024e to ...

8h / 12m 8h / 12m 1 EN

Damien Choplain ... (+2)

Damien Choplain
Martial Descoutures

Novo Nordisk : Diabetes franchise leading the way

>Insulin business in the spotlight - Novo Nordisk’s Q1 2024 results, reported this morning, beat expectations for revenues and margins: +2% ahead of expectations for the top line (DKK 65.5bn, +24% cc) and 9% better for EBIT (DKK 31.9bn, +30% cc). The GLP-1 franchise, driven by Ozempic (+65% cc), is keeping up the pace, with an increase in market share in its diabetes franchise and positive volume momentum (6% growth in GLP-1 prescriptions). But this release was m...

8h / 18m 8h / 18m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Adevinta : Takeover bid at NOK 115/share from the Permira-Blackstone consortium. Neutral vs Outperform

Credit Morning 04/25/2024

Morning Crédit 25/04/2024

Credit Morning 02/29/2024

Ørsted : Good performance in offshore encouraging

Leifheit AG : Making life at home easier and more convenient

Novo Nordisk : Diabetes franchise leading the way

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe